3
Publications
41
Citations
3
H-Index
2021
Active since
Kewon Kim is an author at Korea Advanced Institute of Science and Technology specializing in molecular oncology, extracellular matrix, and tumor biology.
Top concepts
MedicineOncologyCell BiologyPharmacologyTumor BiologyCancer BiologyCancer TherapyCancer ResearchMolecular OncologyRadiation Oncology
Publications per year
2021–2022
3
3
A novel DDR1 inhibitor enhances the anticancer activity of gemcitabine in pancreatic cancer.
Soyeon Ko, Kyung Hee Jung, Young‐Chan Yoon et al. · PubMed · 2022 · 12 citations · Full text
Rows per page
1–3 of 3